Ranbaxy loses exclusivity on heartburn drug in US || Investment Idea

Drug maker Ranbaxy’s troubles with the US Food and Drug Administration (FDA) continue, with the American regulator allowing Israel-based Teva Pharma to launch the generic of Nexium, a heartburn medicine from the AstraZeneca stable. Nexium makes about $4 billion in global sales. Ranbaxy’s loss, meanwhile, could be gain for drug major Cipla, which provides Teva Pharma formulations for Nexium generic. Teva’s benefit from an early entry into one of the biggest drug opportunities will have a rub-off on the Mumbai-based Cipla.

 

Investment Idea

- BUY NCC ABOVE 76 TARGETS-76.7,77.4,78.1 SL-74.5 .

- SELL JINDAL SAW BELOW 88.6 TARGETS- 87.8,87,86.2              SL-90.2 .

                  

Equity Report Daily & Stocks Recommendation By Moneymaker Research

Benchmark shares indices gained for the fifth straight day and also ended at record highs for the second straight session after the International Monetary Fund said that India will grow at a faster pace than China in fiscal 2017. The 30-share Sensex ended at a fresh record closing high of 28,889 after hitting a record high of 28,958.10 and the 50-share Nifty ended at a fresh record closing high of 8,730 after touching a life time high of 8,741.85. On the sectoral front, BSE Consumer Durables index emerged as the top gainer up 1.4% followed by BSE Capital Goods, IT and Teck indices gaining up to 1%. BSE Bankex was up 0.4%. However, BSE FMCG and Metal indices lost sheen and were down over 2% and 0.6%, respectively. The rupee trimmed its initial gains, but was still quoting up by 7 paise to 61.62 against the US currency in late morning deals today on bouts of dollar selling by banks and exporters.

Stocks Recommendation @ Investment advises 

@ Buy mahindra CIE above 248 targets 250.5, 253, 255.5 sl 243.

@ Buy AIA Engineering above 1110 targets 1120, 1130, 1140 sl 1090.

@ Sell Kesoram Industries below 129.5 targets 128.3, 127, 125.7 stop loss 132.

Wipro 5.4% increase in profits @ Live Updates Money Maker

Wipro net profit in the third quarter of fiscal 2015 increased 5.4 per cent to Rs 2198 crore. Wipro net profit in the second quarter of fiscal year 2015 was Rs 2085 crore. Wipro has announced interim dividend of Rs 5 per share.

In the third quarter of fiscal year 2015 earnings by 1.3 percent to $ 179.54 million to Wipro. In the second quarter of fiscal year 2015 revenues of $ 177.15 million was Wipro.

In the third quarter of fiscal year 2015 revenues of Wipro's IT Service 11 344 crore. Wipro's IT service on a quarterly basis in the third quarter, down 21.8 per cent from 22 per cent margin.

Wipro's fourth quarter revenue of $ 181.4 to 185 million dollars from the IT Service has estimated. Wipro CFO Suresh commander from April 1, 2015, will retire from his post. Wipro's new CFO Joe will replace captain Suresh Dalal.